Side-by-side comparison of AI visibility scores, market position, and capabilities
Chinese premium EV brand with pioneering battery-swap network; 326K deliveries in 2025, expanding into Europe with ONVO mass-market sub-brand.
NIO Inc. is a Chinese premium electric vehicle company headquartered in Shanghai and listed on the NYSE, Hong Kong, and Singapore exchanges. The company delivered 326,028 vehicles in 2025, driven by its flagship ET7, ES8, EC6, and EC7 models as well as initial volumes from its new ONVO brand targeting the mass-market segment. NIO is known for its unique Battery-as-a-Service (BaaS) subscription model and an expanding network of over 2,500 battery swap stations across China and Europe.\n\nNIO's battery swap technology allows drivers to exchange a depleted battery for a fully charged one in approximately three minutes at automated stations, addressing range anxiety without requiring long charging stops. The company has deployed swap stations in Norway and Germany as part of its European expansion strategy, distinguishing NIO from competitors like Tesla that rely on fixed charging infrastructure. NIO also sells and leases battery packs separately from vehicles, reducing upfront purchase price through BaaS subscriptions.\n\nThe company has launched ONVO as a mass-market EV sub-brand targeting families and mainstream buyers in China, and Firefly as an ultra-compact urban mobility brand. NIO invests heavily in its own autonomous driving technology (NIO Aquila and NIO Adam super-computing platform) and offers a premium in-car experience including a live concierge service, over-the-air updates, and community-focused NIO Houses lifestyle spaces. Despite strong brand equity, NIO has faced profitability challenges due to high R&D spend and competitive pricing pressure in China.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.